Reimagining Therapeutic Formulations

We are resolving the complexity of therapeutics with nanotechnology and AI.

Down arrow button for quickly scrolling.
"ML Insights & MetricsTM is at the forefront of next-gen therapeutic delivery. We are reshaping how we look at medicine in the next 10 years."

Andrew Tse, PhD

Founder, ML Insights & MetricsTM

nanoML

nanoMLTM is our flagship analytics platform - leveraging AI to make nanoparticle data accessible.

Learn more

An icon representing a nanoparticle.

Nanoparticles

Nanoparticles makes targeted delivery of therapeutics possible, making them safer and more effective

An icon representing drug delivery.

Drug Delivery Biology

Our expertise in drug delivery biology allow us to integrate nanoparticles and AI

An icon representing an artificial intelligence algorithm.

AI & Computational Biophysics

Leverage generative AI to predict the most optimal therapy and nanoparticle combination

Our Story

Welcome to ML Insights & MetricsTM, where AI and big data meet to drive scientific advancements. We specialize in harnessing AI and machine learning to revolutionize nanoparticle drug formulation design and accelerate access to novel drug formulations.

Our mission is to break barriers that limit pharmaceutical advancements and increase accessibility to blockbuster drugs by leveraging the combined knowledge of the scientific community and AI to design nanoparticle formulations for targeted drug delivery.

We empower scientists with the tools and knowledge to streamline the development process, and test and validate their formulations in silico, and identify promising candidates that enhance therapeutic outcomes.

Join us on our journey to redefine nanoparticle formulation design and pioneer pharmaceutical innovation. Together, we can shape the future of healthcare by unlocking the potential of AI and machine learning to deliver safer and more effective treatments to improve lives globally.

Mission

Our vision is to empower scientists with an AI-augmented platform that enhances how they design, validate, and personalize therapeutic delivery with nanotechnology.

An icon of a pill and a beaker.

Accessible

Support due diligence and hypothesis generation based on empirical data

An icon of a pill and a shield.

Safe

Derisk and accelerate formulation R&D from preclinical data

An icon of a pill and a target.

Effective

Develop and investigate optimal formulations for targeted therapeutic delivery